October NIAMRRE Member Spotlight Webinar with Innoceleris

Loading Events

This is a member-only event.

October 5 | 12-1 p.m. (CT)  | Free for Members

Accelerating Your Research Through Innovation, Quality, and Prompt Service

Formally funded in 2019, Innoceleris is a Biotech Research & Consultancy company specialized in the discovery and validation of biomarkers to accelerate the development of ready-to-use reagents and assay platforms for diagnosis, monitoring, and surveillance, and modeling emerging zoonotic and animal infectious diseases. We also provide consultancy services from coast to coast and at all levels: management, design and development, implementation, validation, monitoring, and oversight. Visit www.innoceleris.us for more information.

Event Presenter


Luis Gimenez Lirola

I have over 20 years of experience in the field of infectious diseases affecting both human and production animals. Overall, my scientific background and academic education blended in the interface of academia-industry. I obtained a Biochemistry degree and a Master of Science degree in Biochemistry in June of 2002. Right after my graduation, I joined Vircell Microbiologist, where I spent 10 years working in different positions from ELISA specialist to Production and Q&C Director. Vircell is a biotech company specialized in the development and production of ready-to-use reagents for the diagnosis of infectious diseases in humans by different techniques, ranging from traditional cell culture to the most innovative developments in the field of molecular biology. During this time, I completed a master’s degree in Occupational Risk Prevention (2005) and a PhD in Molecular and Cellular Biology (2009). In 2010, I co-founded the start-up company Rekom Biotech, where I worked as Operation Director until 2011. In 2011, I decided to accept a postdoctoral position at the Iowa State University Veterinary Diagnostic and Production Animal Medicine (VDAPM), and 10 years later, I am occupying the position of Associate Professor in VDPAM. Finally, I funded Innoceleris LLC., in 2019. Overall, my scientific background and academic education have been oriented to the understanding of the immune response against emerging, re-emerging, and zoonotic viral diseases, screening of biomarkers of infection, and the development of cost-effective methods to monitor, quantify, and ameliorate the effect of pathogens on health and livestock productivity.


Autumn Dove—PhD Student, University of Florida, Microbiology and Cell Science

Autumn is a third-year PhD student in the Microbiology and Cell Science Department at the University of Florida in Dr. Daniel Czyz’s lab. She graduated from Northern Arizona University with a BS in biology and a BA in Spanish. Her current research focus is using drug repurposing to modulate the host immune response against antimicrobial resistant infections to find novel therapeutics.

Registration Dates

Registration runs through Tuesday, October 5, until the webinar begins.

Pricing Information

  • Member: Free/$0



Erica Hellmich | 515.294.3352 | ericah@niamrre.org


October 5, 2021
12:00 pm - 1:00 pm UTC+0
Event Tags:
, , ,
Go to Top